RBD5044

· Suzhou Ribo Life Science Co. Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for RBD5044, covering 2024-12-04 to 2026-03-12. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2 Trial Evaluating the Efficacy and Safety of RBD5044 in Patients With Mixed Dyslipidemia [Phase 2]